Peringkat dalam Saham
#39774
Hexima Limited is a biotechnology firm focused on the discovery and advancement... Hexima Limited is a biotechnology firm focused on the discovery and advancement of plant-derived proteins and peptides for medical applications in humans. Its primary drug candidate, pezadeftide, a plant defensin, is presently undergoing Phase IIb clinical evaluations in Australia and New Zealand to address fungal toenail infections. The company was established in 1997 and its main operations are situated in Preston, Australia.
Harga Saham
$0.0084929
Terakhir disinkronkan: 2024-11-12
Kapitalisasi Pasar
$354.66K
Perubahan (1 hari)
-0.64%
Perubahan (1 tahun)
0.00%
Perdagangan Hexima Limited (HXL)
Harga HXL dengan kapitalisasi pasar B
Kapitalisasi pasar dari Hexima Limited(HXL)
Kapitalisasi Pasar: $354.66K
Per August 2026, Hexima Limited memiliki kapitalisasi pasar sebesar $354.66K. Ini menjadikan Hexima Limited sebagai perusahaan 39774th paling bernilai di dunia menurut data kami. Kapitalisasi pasar adalah nilai total saham beredar dari perusahaan publik dan biasanya digunakan untuk mengukur seberapa besar nilai sebuah perusahaan.
Riwayat kapitalisasi pasar Hexima Limited dari 2007 hingga 2026
HXL dibandingkan dengan 5 teratas stocks paling populer
| Harga HXL |
|
Aset B |
Pasar B |
Hasil |
|
|
|
|
$5.470T
|
+1,542,179,604.34%
|
|
|
|
|
$4.467T
|
+1,259,526,175.73%
|
|
|
|
|
$4.174T
|
+1,177,001,356.73%
|
|
|
|
|
$3.700T
|
+1,043,266,143.47%
|
|
|
|
|
$2.854T
|
+804,804,539.63%
|
